PBYI - Puma Biotechnology's (PBYI) CEO Alan Auerbach on Q3 2020 Results - Earnings Call Transcript

Puma Biotechnology, Inc. (PBY) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Mariann Ohanesian – Senior Director-Investor Relations Alan Auerbach – Chief Executive Officer, President, and Chairman of the Board Jeff Ludwig – Chief Commercial Officer Maximo Nougues – Chief Financial Officer Conference Call Participants Ed White – H.C. Wainwright & Company Samantha Semenkow – Citi Kennen MacKay – RBC Capital Markets Laura Christianson – Cowen and Company Presentation Operator Greetings ladies and gentlemen. Thank you for joining the Puma Biotechnology’s Third Quarter Earnings Call. At this time, all participants are in listen-only mode. [Operator Instructions] Please note that this conference is being recorded. I will now turn the conference over to your host Mariann Ohanesian, Senior Director. Thank you. You may begin. Mariann Ohanesian Thank you, Diego. Good afternoon. And welcome to Puma’s conference call to discuss our financial results for the third quarter

For further details see:

Puma Biotechnology's (PBYI) CEO Alan Auerbach on Q3 2020 Results - Earnings Call Transcript